Cyberonics Announces Results from E-36 Study Of AspireSR Generator at AES
December 08, 2013 at 16:49 PM EST
Cyberonics (NASDAQ: CYBX ) announced today that results from the E-36 clinical study of the AspireSR generator were presented at the annual AES Meeting, taking place December 6-10 at the Walter E. Washington Convention Center in Washington, D.C. The study met its primary endpoint in that the AspireSR generator, with
